Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1991 1
1993 1
1998 2
2002 1
2004 1
2007 1
2008 1
2009 2
2012 1
2020 1
2021 3
2022 1
2023 2
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials.
Kaul I, Sawchak S, Claxton A, Sauder C, Hassman HH, Kakar R, Walling DP, Citrome L, Zhu H, Miller AC, Brannan SK. Kaul I, et al. Among authors: hassman hh. Schizophrenia (Heidelb). 2024 Nov 2;10(1):102. doi: 10.1038/s41537-024-00525-6. Schizophrenia (Heidelb). 2024. PMID: 39488504 Free PMC article.
Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial.
Dunbar J, Walling DP, Hassman HA, Jain R, Czysz A, Nandy I, Ona V, Moseley MK, Levin S, Maruff P. Dunbar J, et al. Among authors: hassman ha. J Psychopharmacol. 2024 Dec;38(12):1122-1136. doi: 10.1177/02698811241282777. Epub 2024 Oct 11. J Psychopharmacol. 2024. PMID: 39394685 Free PMC article. Clinical Trial.
Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial.
Burns DK, Alexander RC, Welsh-Bohmer KA, Culp M, Chiang C, O'Neil J, Evans RM, Harrigan P, Plassman BL, Burke JR, Wu J, Lutz MW, Haneline S, Schwarz AJ, Schneider LS, Yaffe K, Saunders AM, Ratti E; TOMMORROW study investigators. Burns DK, et al. Lancet Neurol. 2021 Jul;20(7):537-547. doi: 10.1016/S1474-4422(21)00043-0. Lancet Neurol. 2021. PMID: 34146512 Clinical Trial.
Development of a clinical global impression scale for fatigue.
Targum SD, Hassman H, Pinho M, Fava M. Targum SD, et al. Among authors: hassman h. J Psychiatr Res. 2012 Mar;46(3):370-4. doi: 10.1016/j.jpsychires.2011.12.001. Epub 2012 Jan 10. J Psychiatr Res. 2012. PMID: 22236834
20 results